The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of immune checkpoint inhibitors in patients with advanced pancreatic NETs displaying high TMB and MMR alterations following treatment with alkylating agents.
 
Jonathan Strosberg
Consulting or Advisory Role - Boehringer Ingelheim; Exelixis
Research Funding - Alphamedix (Inst); ITM Solucin (Inst); Novartis (Inst); RayzeBio (Inst)
 
Anna Koumarianou
Consulting or Advisory Role - BMSi; MSD
 
Rachel Riechelmann
No Relationships to Disclose
 
Jorge Hernando
Speakers' Bureau - Advanced Accelerator Applications; Angelini Pharma; Bayer; Eisai; Ipsen; Novartis; Roche
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Eisai; Ipsen; Novartis; Roche
 
Sara Cingarlini
No Relationships to Disclose
 
Joakim Crona
Stock and Other Ownership Interests - AstraZeneca
 
Taymeyah Al-Toubah
No Relationships to Disclose
 
Leonidas Apostolidis
Honoraria - BMS; Ipsen; Novartis
Consulting or Advisory Role - Novartis
Research Funding - Camurus (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen; Novartis
 
Emily Bergsland
Leadership - More Health (I)
Stock and Other Ownership Interests - exai bio (I); More Health (I)
Research Funding - Boehringer Ingelheim (Inst); Merck (Inst); RayzeBio (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Thorvardur Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Boehringer Ingelheim; Camurus (Inst); Crinetics Pharmaceuticals (Inst); Curium Pharma; Exelixis; Ipsen (Inst); ITM Isotope Technologies Munich (Inst); Perspective Therapeutics (Inst); Tersera; Viewpoint Molecular Targeting (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Crinetics Pharmaceuticals (Inst); ITM Isotope Technologies Munich (Inst); Novartis (Inst); Perspective Therapeutics (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)
(OPTIONAL) Uncompensated Relationships - North American Neuroendocrine Tumor Society
 
Jerome Cros
Consulting or Advisory Role - Esteve
 
Louis De Mestier DU Bourg
Consulting or Advisory Role - Esteve; Ipsen; Mayoly-Spindler; Novartis; SERVIER; vitaris